Cite

HARVARD Citation

    Pilotto, S. et al. (n.d.). An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer. Expert opinion on investigational drugs. pp. 1143-1161. [Online]. 
  
Back to record